Dr. Tohen's research reflects more than 20 years of work in clinical epidemiology and clinical trials in the area of bipolar disorder. His research integrates academic and industry work, and his current projects include clinical trials in bipolar disorder and clinical epidemiology of bipolar disorder with a focus on first episode patients.
Positions
Director of Bipolar Disorder Program, University of San Antonio, Texas, USA
Distinguished Lilly Scholar, Lilly Research Laboratories, Indianapolis, IN
Associate Clinical Professor, Psychiatry, McLean Hospital, Harvard Medical School, Boston, MA
Education
M.D., 1976, National University of Mexico
Dr.P.H., 1988, Harvard University, Public Health
MBA, 2000, Kelly School of Business, Indiana University
Relevant Publications
· Tohen M, Waternaux CM, Tsuang MT. Outcome in mania: a four year prospective follow-up of 75 patients utilizing survival analysis. Arch Gen Psych. 1990;47(12):1106-1111.
· Tohen M, Hennen J, Zarate C, et al. Two-year syndromal and functional recovery in 219 cases of major affective disorders with psychotic features. Am J Psychiatry. 2000;157(2):220-228.
· Tohen M, Zarate CA, Hennen J, et al. The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence. Am J Psychiatry. 2003;160(12):2099-2107.
· Tohen M, Vieta E, Calabrese J, et al. Efficacy of olanzapine and olanzapine/fluoxetine in combination in the treatment of bipolar I depression [erratum appears in Arch Gen Psych. 2004;61(2):176]. Arch Gen Psych. 2003;60(11):1079-1088.
· Tohen M. Clinical trials in bipolar mania: implications in study design and drug development. Arch Gen Psych. 2008;65(3):252-253.
